Merck's small molecule cancer drug, acquired for over $1.3 billion, launches Phase 3 clinical trials in China
芊芊551
发表于 2024-7-24 18:35:33
198
0
0
According to the latest announcement on the Chinese Drug Clinical Trial Registration and Information Disclosure Platform, Merck's Class 1 oral drug MK-3543 (bomedemstat) for the treatment of primary thrombocytopenia has started Phase 3 clinical trials. Bomedemstat is an oral lysine specific demethylase 1 (LSD1) inhibitor, which Merck acquired from Imago BioSciences for approximately $1.35 billion in 2022.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
- Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
- The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
- When will Apple AI be launched in China? Cook responds!
- Dialogue with Meng Pu, Chairman of Qualcomm China: Qualcomm has long-term accumulation in China and will adhere to the path of self-developed chips
- This US funded enterprise has clarified its confidence and direction for development in China through the CIIE
- Pfizer's innovative targeted therapy drug Taizena has been approved in China
- AbbVie Dual Anti Cancer New Drug Declares for Market in China
- Abbott announces the launch of its new women's health drug Fenyouning in China
- A sharp drop of 87%! Maserati will only sell over 30 units in China in September! Has the 'Sports Car Queen' fallen from grace?
-
据媒体报道,OpenAI正准备推出一款代号为“Operator”的全新AI助理产品,可以自动执行各种复杂操作,包括编写代码、预订旅行、自动电商购物等。根据内部员工爆料,OpenAI领导层预计将在2025年1月发布该产品,首 ...
- 永远的希望
- 半小时前
- 支持
- 反对
- 回复
- 收藏
-
本报讯 (记者李豪悦)11月12日,腾讯音乐娱乐集团(以下简称“腾讯音乐”)宣布其截至2024年9月30日止第三季度的未经审计财务业绩。 2024年第三季度,腾讯音乐娱乐集团业绩表现稳健,总收入为70.2亿元,同 ...
- 覃志辉
- 前天 20:07
- 支持
- 反对
- 回复
- 收藏
-
新华财经上海11月13日电芯片制造商英伟达和软银集团的电信部门软银公司周三表示,两家公司已经试运行了全球首个人工智能和5G电信网络。 两家公司表示,该网络可以同时运行人工智能和5G工作负载,这一过程被 ...
- 惡魔獵人
- 昨天 12:36
- 支持
- 反对
- 回复
- 收藏
-
美股三大指数集体收跌,道指跌0.86%,标普500指数跌0.29%,纳指跌0.09%。大型科技股多数上涨,英伟达涨超2%,奈飞、微软、亚马逊涨超1%,谷歌、Meta小幅上涨;苹果平收,特斯拉跌超6%,英特尔跌超3%。安进收跌超 ...
- lbbz1314
- 昨天 09:59
- 支持
- 反对
- 回复
- 收藏